Greater response to placebo in children than in adults: a systematic review and meta-analysis in drug-resistant partial epilepsy.

<h4>Background</h4>Despite guidelines establishing the need to perform comprehensive paediatric drug development programs, pivotal trials in children with epilepsy have been completed mostly in Phase IV as a postapproval replication of adult data. However, it has been shown that the trea...

Full description

Saved in:
Bibliographic Details
Main Authors: Sylvain Rheims, Michel Cucherat, Alexis Arzimanoglou, Philippe Ryvlin
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2008-08-01
Series:PLoS Medicine
Online Access:https://doi.org/10.1371/journal.pmed.0050166
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849685305728172032
author Sylvain Rheims
Michel Cucherat
Alexis Arzimanoglou
Philippe Ryvlin
author_facet Sylvain Rheims
Michel Cucherat
Alexis Arzimanoglou
Philippe Ryvlin
author_sort Sylvain Rheims
collection DOAJ
description <h4>Background</h4>Despite guidelines establishing the need to perform comprehensive paediatric drug development programs, pivotal trials in children with epilepsy have been completed mostly in Phase IV as a postapproval replication of adult data. However, it has been shown that the treatment response in children can differ from that in adults. It has not been investigated whether differences in drug effect between adults and children might occur in the treatment of drug-resistant partial epilepsy, although such differences may have a substantial impact on the design and results of paediatric randomised controlled trials (RCTs).<h4>Methods and findings</h4>Three electronic databases were searched for RCTs investigating any antiepileptic drug (AED) in the add-on treatment of drug-resistant partial epilepsy in both children and adults. The treatment effect was compared between the two age groups using the ratio of the relative risk (RR) of the 50% responder rate between active AEDs treatment and placebo groups, as well as meta-regression. Differences in the response to placebo and to active treatment were searched using logistic regression. A comparable approach was used for analysing secondary endpoints, including seizure-free rate, total and adverse events-related withdrawal rates, and withdrawal rate for seizure aggravation. Five AEDs were evaluated in both adults and children with drug-resistant partial epilepsy in 32 RCTs. The treatment effect was significantly lower in children than in adults (RR ratio: 0.67 [95% confidence interval (CI) 0.51-0.89]; p = 0.02 by meta-regression). This difference was related to an age-dependent variation in the response to placebo, with a higher rate in children than in adults (19% versus 9.9%, p < 0.001), whereas no significant difference was observed in the response to active treatment (37.2% versus 30.4%, p = 0.364). The relative risk of the total withdrawal rate was also significantly lower in children than in adults (RR ratio: 0.65 [95% CI 0.43-0.98], p = 0.004 by metaregression), due to higher withdrawal rate for seizure aggravation in children (5.6%) than in adults (0.7%) receiving placebo (p < 0.001). Finally, there was no significant difference in the seizure-free rate between adult and paediatric studies.<h4>Conclusions</h4>Children with drug-resistant partial epilepsy receiving placebo in double-blind RCTs demonstrated significantly greater 50% responder rate than adults, probably reflecting increased placebo and regression to the mean effects. Paediatric clinical trial designs should account for these age-dependent variations of the response to placebo to reduce the risk of an underestimated sample size that could result in falsely negative trials.
format Article
id doaj-art-fb2a20c4cb8046bd97338064bec0cecb
institution DOAJ
issn 1549-1277
1549-1676
language English
publishDate 2008-08-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS Medicine
spelling doaj-art-fb2a20c4cb8046bd97338064bec0cecb2025-08-20T03:23:11ZengPublic Library of Science (PLoS)PLoS Medicine1549-12771549-16762008-08-0158e16610.1371/journal.pmed.0050166Greater response to placebo in children than in adults: a systematic review and meta-analysis in drug-resistant partial epilepsy.Sylvain RheimsMichel CucheratAlexis ArzimanoglouPhilippe Ryvlin<h4>Background</h4>Despite guidelines establishing the need to perform comprehensive paediatric drug development programs, pivotal trials in children with epilepsy have been completed mostly in Phase IV as a postapproval replication of adult data. However, it has been shown that the treatment response in children can differ from that in adults. It has not been investigated whether differences in drug effect between adults and children might occur in the treatment of drug-resistant partial epilepsy, although such differences may have a substantial impact on the design and results of paediatric randomised controlled trials (RCTs).<h4>Methods and findings</h4>Three electronic databases were searched for RCTs investigating any antiepileptic drug (AED) in the add-on treatment of drug-resistant partial epilepsy in both children and adults. The treatment effect was compared between the two age groups using the ratio of the relative risk (RR) of the 50% responder rate between active AEDs treatment and placebo groups, as well as meta-regression. Differences in the response to placebo and to active treatment were searched using logistic regression. A comparable approach was used for analysing secondary endpoints, including seizure-free rate, total and adverse events-related withdrawal rates, and withdrawal rate for seizure aggravation. Five AEDs were evaluated in both adults and children with drug-resistant partial epilepsy in 32 RCTs. The treatment effect was significantly lower in children than in adults (RR ratio: 0.67 [95% confidence interval (CI) 0.51-0.89]; p = 0.02 by meta-regression). This difference was related to an age-dependent variation in the response to placebo, with a higher rate in children than in adults (19% versus 9.9%, p < 0.001), whereas no significant difference was observed in the response to active treatment (37.2% versus 30.4%, p = 0.364). The relative risk of the total withdrawal rate was also significantly lower in children than in adults (RR ratio: 0.65 [95% CI 0.43-0.98], p = 0.004 by metaregression), due to higher withdrawal rate for seizure aggravation in children (5.6%) than in adults (0.7%) receiving placebo (p < 0.001). Finally, there was no significant difference in the seizure-free rate between adult and paediatric studies.<h4>Conclusions</h4>Children with drug-resistant partial epilepsy receiving placebo in double-blind RCTs demonstrated significantly greater 50% responder rate than adults, probably reflecting increased placebo and regression to the mean effects. Paediatric clinical trial designs should account for these age-dependent variations of the response to placebo to reduce the risk of an underestimated sample size that could result in falsely negative trials.https://doi.org/10.1371/journal.pmed.0050166
spellingShingle Sylvain Rheims
Michel Cucherat
Alexis Arzimanoglou
Philippe Ryvlin
Greater response to placebo in children than in adults: a systematic review and meta-analysis in drug-resistant partial epilepsy.
PLoS Medicine
title Greater response to placebo in children than in adults: a systematic review and meta-analysis in drug-resistant partial epilepsy.
title_full Greater response to placebo in children than in adults: a systematic review and meta-analysis in drug-resistant partial epilepsy.
title_fullStr Greater response to placebo in children than in adults: a systematic review and meta-analysis in drug-resistant partial epilepsy.
title_full_unstemmed Greater response to placebo in children than in adults: a systematic review and meta-analysis in drug-resistant partial epilepsy.
title_short Greater response to placebo in children than in adults: a systematic review and meta-analysis in drug-resistant partial epilepsy.
title_sort greater response to placebo in children than in adults a systematic review and meta analysis in drug resistant partial epilepsy
url https://doi.org/10.1371/journal.pmed.0050166
work_keys_str_mv AT sylvainrheims greaterresponsetoplaceboinchildrenthaninadultsasystematicreviewandmetaanalysisindrugresistantpartialepilepsy
AT michelcucherat greaterresponsetoplaceboinchildrenthaninadultsasystematicreviewandmetaanalysisindrugresistantpartialepilepsy
AT alexisarzimanoglou greaterresponsetoplaceboinchildrenthaninadultsasystematicreviewandmetaanalysisindrugresistantpartialepilepsy
AT philipperyvlin greaterresponsetoplaceboinchildrenthaninadultsasystematicreviewandmetaanalysisindrugresistantpartialepilepsy